v3.26.1
Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Total revenues $ 218,250   $ 163,353   $ 374,663 $ 308,887
Less            
Cost of product sales 3,840   2,798   9,217 7,366
Stock-based compensation         30,719 42,672
Interest expense 21,712   21,582   41,491 45,076
Loss on extinguishment of debt 0   4,171   0 4,171
Income tax expense 1,079   1,401   2,083 2,127
Net income (loss) 78,395 $ (721,812) 5,085 $ 32 (643,417) 5,117
Reportable Segment            
Segment Reporting [Line Items]            
Total revenues 218,250   163,353   374,663 308,887
Less            
Cost of product sales 3,840   2,798   9,217 7,366
Acquired in-process research and development 0   0   697,761 0
Sales and marketing (excluding stock-based compensation) 33,947   45,589   76,900 93,259
General and administrative (excluding stock-based compensation) 20,810   29,817   63,203 51,776
Stock-based compensation 14,692   21,304   30,719 42,672
Interest income (2,434)   (2,516)   (4,690) (5,540)
Interest expense 21,712   21,582   41,491 45,076
Foreign currency (gains) losses (27)   63   198 62
Loss on extinguishment of debt 0   4,171   0 4,171
Other (income) expense, net (260)   0   1,202 0
Income tax expense 1,079   1,401   2,083 2,127
Net income (loss) 78,395   5,085   (643,417) 5,117
Reportable Segment | Navenibart            
Less            
Research and development (excluding stock-based compensation) 17,328   0   27,069 0
Reportable Segment | BCX17725            
Less            
Research and development (excluding stock-based compensation) 5,240   3,316   7,147 5,772
Reportable Segment | Berotralstat            
Less            
Research and development (excluding stock-based compensation) 1,611   4,766   3,407 6,640
Reportable Segment | Avoralstat            
Less            
Research and development (excluding stock-based compensation) 351   3,305   1,244 5,784
Reportable Segment | STAR-0310            
Less            
Research and development (excluding stock-based compensation) 91   0   774 0
Reportable Segment | Research, discovery and preclinical programs            
Less            
Research and development (excluding stock-based compensation) 3,441   3,560   7,411 6,604
Reportable Segment | Compensation and related personnel costs            
Less            
Research and development (excluding stock-based compensation) 11,390   12,369   38,481 24,712
Reportable Segment | Other non-program specific and indirect costs            
Less            
Research and development (excluding stock-based compensation) $ 7,044   $ 6,743   $ 14,463 $ 13,289